Furthermore, disturbances in irisin, MSTN, and adiponectin levels—factors involved in muscle-adipose tissue crosstalk—may indicate an increased risk for the development of metabolic disorders in patients with PWS later in life. This evidence concerns the gene FNDC5 and metabolic disease.